Special Issue on Biomarkers! As defined by the FDA, a biomarker is defined characteristic that is measured as an indicator of normal biological processes, pathogenic processes, or responses to an exposure or intervention, including therapeutic interventions. The manuscript submission deadline is October 15, 2024.
Read More